HARBOR INVESTMENT ADVISORY, LLC

Position in HLN — Haleon plc

CIK 1468792 LUTHERVILLE, MD

Position in HLN

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$933

-$68 QoQ

Shares Held

100

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#604

of 639 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR INVESTMENT ADVISORY, LLC holds $593,119 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	614	$332,683
2	NBIX	Neurocrine Biosciences Inc	660	$111,236
3	ALKS	Alkermes plc.	1,556	$81,526
4	ZTS	Zoetis Inc.	716	$51,451
5	VTRS	Viatris Inc	960	$15,244
6	HLN	Haleon plc This page	100	$933
7	TEVA	Teva Pharmaceutical Industries Ltd	1	$33
8	CRON	Cronos Group Inc.	5	$13

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$933	100	0.0%	Shares	Sole	2026-07-07
2026-03-31	$1,001	100	0.0%	Shares	Sole	2026-04-23
2025-12-31	$1,011	100	0.0%	Shares	Sole	2026-01-07
2025-09-30	$897	100	0.0%	Shares	Sole	2025-10-27
2025-06-30	$1,037	100	0.0%	Shares	Sole	2025-07-01
2025-03-31	$1,029	100	0.0%	Shares	Sole	2025-04-09
2024-12-31	$954	100	0.0%	Shares	Sole	2025-01-16
2024-09-30	$1,058	100	-78.3%	Shares	Sole	2024-10-04
2024-06-30	$3,807	461	0.0%	Shares	Sole	2024-07-19
2024-03-31	$3,913	461	+28.4%	Shares	Sole	2024-04-12
2023-12-31	$2,954	359	-20.2%	Shares	Sole	2024-01-26
2023-09-30	$3,748	450	-36.3%	Shares	Sole	2023-10-13
2023-06-30	$5,916	706	+21.1%	Shares	Sole	2023-07-14
2023-03-31	$4,745	583	0.0%	Shares	Sole	2023-04-21
2022-12-31	$4,664	583	+29.8%	Shares	Sole	2023-01-24
2022-09-30	$2,734	449	—	Shares	Sole	2022-11-01
No filing history on record for this holder in this stock.